FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Denver Solutions, LLC DBA Leiters Health Moxifloxacin Recall

Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/c…

Denver Solutions, LLC DBA Leiters Health · Englewood, CO

Risk level
Class II
Reported by FDA
Dec 29, 2021
Recall ID
D-0288-2022
Check your lot numberHow we source this data

Summary

Denver Solutions, LLC DBA Leiters Health recalled Moxifloxacin starting Nov 29, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0288-2022 on Dec 29, 2021. Reason: Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL. Status: Terminated.

Why it was recalled

Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL

Product description

Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42

Lot numbers, UPCs & expiration codes

Lot #: 2130958; Expiration Date 03/31/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0288-2022
Classification
Class II
Status
Terminated
Recall initiated
Nov 29, 2021
FDA report date
Dec 29, 2021
Quantity
1440 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Denver Solutions, LLC DBA Leiters Health

Original FDA data

Every field from FDA enforcement report D-0288-2022, exactly as published.

Show all FDA fields
City
Englewood
State
CO
Status
Terminated
Country
United States
Event ID
89136
Address
13796 Compark Blvd
Code information
Lot #: 2130958; Expiration Date 03/31/2022
Postal code
80112-7145
Report date
Dec 29, 2021
Product type
Drugs
Recall number
D-0288-2022
Classification
Class II
Recalling firm
Denver Solutions, LLC DBA Leiters Health
Product quantity
1440 vials
Termination date
Jul 12, 2022
Reason for recall
Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL
Voluntary / mandated
Voluntary: Firm initiated
Product description
Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42
Distribution pattern
Nationwide within the United States
Recall initiation date
Nov 29, 2021
Initial firm notification
Telephone
Center classification date
Dec 17, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0288-2022, published Dec 29, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls